Text and Data Mining valid from 2018-11-19
Received: 17 August 2018
Accepted: 10 October 2018
First Online: 19 November 2018
: C.F.K. has a sponsored research agreement with Celgene Corporation and has received honorarium from AstraZeneca and MedImmune. K.K.W. is a founder and equity holder of G1 Therapeutics and he has Consulting/Sponsored Research Agreements with AstraZeneca, Janssen, Pfizer, Array, Novartis, Merck, Takeda, Ono, and BMS. S.P.R., A.F.M.D., S.M.L., B.P.M., P.P., C.R.A., C.F.B., S.J.T., H.W., A.L., S.R., B.J.A., F.L., and T.M.S. have no competing interests.